Glaxo SmithKline Consumer Nigeria Plc released its full-year results for the year ended 31st December 2020.
- Revenue for the year was N21.3 billion. (+2.6% YoY)
- Cost of sales was N15.4 billion. (+4.6% YoY)
- Administrative expenses totaled N1.59 billion. (-17.6% YoY)
- Profit after tax was N622.2 million. (-32.2% YoY)
- Earnings per share of 52 kobo vs 77 kobo YoY.
- A dividend of 40 kobo was proposed.
See link to results.
